Overview
Depending on certain factors, you might qualify for clinical trials studying new myasthenia gravis treatments. These trials are vital for gaining a better understanding of myasthenia gravis and evaluating new… read more
Overview
Imaavy is approved by the U.S. Food and Drug Administration (FDA) for the treatment of generalized myasthenia gravis (gMG) in adults and children aged 12 years and older who test positive for either acetylcholine…
Overview
Bkemv is approved by the U.S. Food and Drug Administration (FDA) for the treatment of generalized myasthenia gravis in adults who test positive for anti-acetylcholine receptor (AchR) antibodies. Bkemv is a…
read moreOverview
Mycophenolate mofetil is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to prevent organ rejection for people receiving transplants, but it is also prescribed off-label to treat… read more
Overview
Azathioprine is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to prevent organ rejection for people receiving transplants, but it is also used to treat autoimmune conditions… read more
Overview
Cyclosporine is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat several autoimmune conditions and is sometimes prescribed to treat myasthenia gravis. Cyclosporine is… read more
Overview
Hyoscyamine is a prescription medication used to control symptoms associated with various health conditions related to the stomach and gastrointestinal (GI) tract, including bladder spasms, irritable bowel… read more
Overview
Glycopyrrolate is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating peptic ulcers in adults. Glycopyrrolate is sometimes used to manage cholinergic side effects of… read more
Overview
Mestinon is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat myasthenia gravis. Mestinon may also be referred to by its drug name, pyridostigmine.
Mestinon is in a class… read more
Overview
Tacrolimus is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to prevent organ rejection for people receiving transplants, but it is also prescribed off-label to treat myasthenia… read more